{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T05:20:34Z","timestamp":1764566434566,"version":"3.46.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The high-altitude environment characterized by hypobaric hypoxia can cause significant damage to the cardiovascular system, particularly vascular endothelial function, and is a significant trigger for acute and chronic mountain sickness. High-altitude pulmonary hypertension (HAPH) is a serious complication induced by prolonged exposure to high altitude, characterized by abnormally elevated pulmonary artery pressure and increased right heart load, which can progress to right heart failure and be life-threatening. This article aims to enhance clinicians\u2019 understanding of this disease through two cases of HAPH in young males.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case description<\/jats:title>\n                    <jats:p>Case 1 was a 21-year-old male who developed progressively worsening chest pain, shortness of breath, and amaurosis fugax after living at an altitude of 4800 meters for 4 months. Case 2 was a 20-year-old male who experienced exertional dyspnea accompanied by amaurosis fugax and a brief loss of consciousness after 18 months of residence at 4,300 meters. Both patients were previously healthy with normal cardiopulmonary function before moving to high altitude. Physical examination upon presentation revealed significant hypoxemia (oxygen saturation 80 and 82% on room air, respectively). Echocardiography in both cases clearly demonstrated right atrial and right ventricular enlargement, moderate tricuspid regurgitation, with estimated systolic pulmonary artery pressures (sPAP) as high as 55 mmHg and 56 mmHg, respectively. Chest CT confirmed right heart enlargement and main pulmonary artery dilation. After systematic evaluation excluded other etiologies, HAPH was diagnosed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The core pathophysiology of HAPH is hypoxia-induced pulmonary vasoconstriction and remodeling. These cases demonstrate that even for young, healthy individuals, prolonged exposure to extremely high altitudes can lead to severe pulmonary hypertension and right ventricular dysfunction. Diagnosis requires a combination of high-altitude exposure history, clinical symptoms, evidence of hypoxemia, and echocardiographic findings. The most fundamental treatment for diagnosed HAPH patients is removal from the high-altitude hypoxic environment, making early recognition and intervention crucial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The high-altitude environment poses a serious threat to the cardiovascular systems of susceptible individuals. For patients with a history of high-altitude residence who present with relevant symptoms, clinicians should maintain a high index of suspicion for HAPH and conduct timely screening and diagnosis to prevent adverse outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1719635","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T05:16:29Z","timestamp":1764566189000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: High altitude, young lives: unmasking pulmonary hypertension in two unique cases"],"prefix":"10.3389","volume":"12","author":[{"given":"Fuguo","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyang","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengxing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingliang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-024-00526-w","article-title":"Altitude illnesses.","volume":"10","author":"Gatterer","year":"2024","journal-title":"Nat Rev Dis Primers."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1042\/CS20242052","article-title":"Evaluation of the cell death markers for aberrated cell free DNA release in high altitude pulmonary edema.","volume":"138","author":"Ali","year":"2024","journal-title":"Clin Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1113\/JP282281","article-title":"GLOBAL REACH 2018: intra-arterial vitamin C improves endothelial-dependent vasodilatory function in humans at high altitude.","volume":"600","author":"Stone","year":"2022","journal-title":"J Physiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1113\/JP282972","article-title":"Global REACH 2018: increased adrenergic restraint of blood flow preserves coupling of oxygen delivery and demand during exercise at high-altitude.","volume":"600","author":"Hansen","year":"2022","journal-title":"J Physiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1093\/ehjcvp\/pvae004","article-title":"Beta-adrenergic blockade increases pulmonary vascular resistance and causes exaggerated hypoxic pulmonary vasoconstriction at high altitude: a physiological study.","volume":"10","author":"Hilty","year":"2024","journal-title":"Eur Heart J Cardiovasc Pharmacother."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e037126","DOI":"10.1161\/JAHA.124.037126","article-title":"Right ventricular stiffening and anisotropy alterations in pulmonary hypertension: mechanisms and relations to right heart failure.","volume":"14","author":"Neelakantan","year":"2025","journal-title":"J Am Heart Assoc."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1093\/cvr\/cvx145","article-title":"RV pressure overload: from hypertrophy to failure.","volume":"113","author":"van der Bruggen","year":"2017","journal-title":"Cardiovasc Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1902474","DOI":"10.1183\/13993003.02474-2019","article-title":"Cardiac function and pulmonary hypertension in Central Asian highlanders at 3250 m.","volume":"56","author":"Lichtblau","year":"2020","journal-title":"Eur Respir J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1089\/ham.2020.0022","article-title":"The prevalence and risk factors of high-altitude pulmonary hypertension among native tibetans in sichuan province, China.","volume":"21","author":"Gou","year":"2020","journal-title":"High Alt Med Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e190957","DOI":"10.1172\/JCI190957","article-title":"Macrophages: key conductors behind perivascular inflammation and vascular remodeling in hypoxia-induced pulmonary hypertension.","volume":"135","author":"Spiekerkoetter","year":"2025","journal-title":"J Clin Invest."},{"key":"B11","doi-asserted-by":"publisher","first-page":"155376","DOI":"10.1016\/j.phymed.2024.155376","article-title":"Salidroside protects pulmonary artery endothelial cells against hypoxia-induced apoptosis via the AhR\/NF-\u03baB and Nrf2\/HO-1 pathways.","volume":"128","author":"Lei","year":"2024","journal-title":"Phytomedicine."},{"key":"B12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jgr.2024.10.002","article-title":"Ginsenoside Rg1 improves hypoxia-induced pulmonary vascular endothelial dysfunction through TXNIP\/NLRP3 pathway-modulated mitophagy.","volume":"49","author":"Zhang","year":"2025","journal-title":"J Ginseng Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41569-023-00924-9","article-title":"Cardiovascular physiology and pathophysiology at high altitude.","volume":"21","author":"Richalet","year":"2024","journal-title":"Nat Rev Cardiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"118109","DOI":"10.1016\/j.biopha.2025.118109","article-title":"Methyleugenol alleviates pulmonary vascular remodeling in rats with high-altitude pulmonary hypertension by improving pulmonary smooth muscle cell function.","volume":"187","author":"Yu","year":"2025","journal-title":"Biomed Pharmacother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.chest.2016.09.001","article-title":"Hypoxic pulmonary vasoconstriction: from molecular mechanisms to medicine.","volume":"151","author":"Dunham-Snary","year":"2017","journal-title":"Chest."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/ham.2024.0037","article-title":"Physiopathology of high-altitude pulmonary edema.","volume":"26","author":"Miserocchi","year":"2025","journal-title":"High Alt Med Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12906-023-03981-2","article-title":"Protective effects of the Terminalia bellirica tannin-induced Nrf2\/HO-1 signaling pathway in rats with high-altitude pulmonary hypertension.","volume":"23","author":"Aimaier","year":"2023","journal-title":"BMC Complement Med Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1001\/jama.287.17.2228","article-title":"Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor.","volume":"287","author":"Swenson","year":"2002","journal-title":"JAMA."},{"key":"B19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1183\/09031936.95.08040523","article-title":"Pathogenesis of high-altitude pulmonary oedema: direct evidence of stress failure of pulmonary capillaries.","volume":"8","author":"West","year":"1995","journal-title":"Eur Respir J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1002\/cphy.c100029","article-title":"High-altitude pulmonary edema.","volume":"2","author":"Swenson","year":"2012","journal-title":"Compr Physiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"767705","DOI":"10.3389\/fphar.2022.767705","article-title":"Chemerin regulates the proliferation and migration of pulmonary arterial smooth muscle cells via the ERK1\/2 signaling pathway.","volume":"13","author":"Peng","year":"2022","journal-title":"Front Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1113\/JP284585","article-title":"Symposium review: high altitude travel with pulmonary vascular disease.","volume":"602","author":"Titz","year":"2024","journal-title":"J Physiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.pcad.2010.02.004","article-title":"New insights in the pathogenesis of high-altitude pulmonary edema.","volume":"52","author":"Scherrer","year":"2010","journal-title":"Prog Cardiovasc Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3390\/ijms26010341","article-title":"Aldose reductase: a promising therapeutic target for high-altitude pulmonary Edema.","volume":"26","author":"Song","year":"2025","journal-title":"Int J Mol Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1297636","DOI":"10.3389\/fphys.2023.1297636","article-title":"Asymmetric and symmetric dimethylarginine in high altitude pulmonary hypertension (HAPH) and high altitude pulmonary edema (HAPE).","volume":"14","author":"Hannemann","year":"2023","journal-title":"Front Physiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"5761","DOI":"10.3390\/jcm10245761","article-title":"Association of genes of the NO pathway with altitude disease and hypoxic pulmonary hypertension.","volume":"10","author":"Hannemann","year":"2021","journal-title":"J Clin Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1164\/ajrccm.162.1.9908039","article-title":"Exhaled nitric oxide in high-altitude pulmonary edema: role in the regulation of pulmonary vascular tone and evidence for a role against inflammation.","volume":"162","author":"Duplain","year":"2000","journal-title":"Am J Respir Crit Care Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4837","DOI":"10.1113\/jphysiol.2010.194704","article-title":"High-altitude pulmonary hypertension is associated with a free radical-mediated reduction in pulmonary nitric oxide bioavailability.","volume":"588","author":"Bailey","year":"2010","journal-title":"J Physiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"169605","DOI":"10.1016\/j.scitotenv.2023.169605","article-title":"Hypobaric hypoxia drives selection of altitude-associated adaptative alleles in the Himalayan population.","volume":"913","author":"Sharma","year":"2024","journal-title":"Sci Total Environ."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1038\/s41467-024-48261-w","article-title":"A time-resolved multi-omics atlas of transcriptional regulation in response to high-altitude hypoxia across whole-body tissues.","volume":"15","author":"Yan","year":"2024","journal-title":"Nat Commun."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1007\/s00018-017-2551-8","article-title":"Critical effects of epigenetic regulation in pulmonary arterial hypertension.","volume":"74","author":"Chen","year":"2017","journal-title":"Cell Mol Life Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00421-022-05066-3","article-title":"century of exercise physiology: lung fluid balance during and following exercise.","volume":"123","author":"Miserocchi","year":"2023","journal-title":"Eur J Appl Physiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1164\/rccm.202012-4317SO","article-title":"Pulmonary arterial hypertension: diagnosis, treatment, and novel advances.","volume":"203","author":"Maron","year":"2021","journal-title":"Am J Respir Crit Care Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1900985","DOI":"10.1183\/13993003.00985-2019","article-title":"Pulmonary hypertension at high altitude.","volume":"53","author":"Naeije","year":"2019","journal-title":"Eur Respir J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1089\/ham.2005.6.147","article-title":"Consensus statement on chronic and subacute high altitude diseases.","volume":"6","author":"Le\u00f3n-Velarde","year":"2005","journal-title":"High Alt Med Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2102311","DOI":"10.1183\/13993003.02311-2021","article-title":"COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension.","volume":"60","author":"Hoeper","year":"2022","journal-title":"Eur Respir J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1183\/09031936.00155009","article-title":"The role of per cent predicted 6-min walk distance in pulmonary arterial hypertension.","volume":"36","author":"Lee","year":"2010","journal-title":"Eur Respir J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1901617","DOI":"10.1183\/13993003.01617-2019","article-title":"Noninvasive evaluation of pulmonary artery pressure during exercise: the importance of right atrial hypertension.","volume":"55","author":"Obokata","year":"2020","journal-title":"Eur Respir J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1700784","DOI":"10.1183\/13993003.00784-2017","article-title":"Evaluation of criteria for exercise-induced pulmonary hypertension in patients with resting pulmonary hypertension.","volume":"50","author":"Mullin","year":"2017","journal-title":"Eur Respir J."},{"key":"B40","doi-asserted-by":"publisher","first-page":"105682","DOI":"10.1016\/j.neubiorev.2024.105682","article-title":"The effects of long-term high-altitude exposure on cognition: a meta-analysis.","volume":"161","author":"Su","year":"2024","journal-title":"Neurosci Biobehav Rev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jad.2022.08.079","article-title":"Prevalence of depression and depressive symptoms at high altitudes: a systematic review and meta-analysis.","volume":"317","author":"Basualdo-Mel\u00e9ndez","year":"2022","journal-title":"J Affect Disord."},{"key":"B42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2174\/1874192401610010019","article-title":"High-altitude pulmonary hypertension: an update on disease pathogenesis and management.","volume":"10","author":"Mirrakhimov","year":"2016","journal-title":"Open Cardiovasc Med J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension.","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur Respir J."},{"key":"B44","doi-asserted-by":"publisher","first-page":"101129","DOI":"10.1016\/j.jpha.2024.101129","article-title":"Advanced treatment strategies for high-altitude pulmonary hypertension employing natural medicines: a review.","volume":"15","author":"Batool","year":"2025","journal-title":"J Pharm Anal."},{"key":"B45","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00421-009-1042-5","article-title":"The effects of sildenafil and acetazolamide on breathing efficiency and ventilatory control during hypoxic exercise.","volume":"106","author":"Lalande","year":"2009","journal-title":"Eur J Appl Physiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1513\/AnnalsATS.202004-327CME","article-title":"COVID-19 lung injury and high-altitude pulmonary edema. A false equation with dangerous implications.","volume":"17","author":"Luks","year":"2020","journal-title":"Ann Am Thorac Soc."},{"key":"B47","doi-asserted-by":"publisher","first-page":"105287","DOI":"10.1016\/j.phrs.2020.105287","article-title":"Resveratrol: mechanistic and therapeutic perspectives in pulmonary arterial hypertension.","volume":"163","author":"Mirhadi","year":"2021","journal-title":"Pharmacol Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"8265","DOI":"10.2147\/DDDT.S531109","article-title":"Chinese herbal medicine in hypoxic pulmonary hypertension treatment: mechanisms, progress, and future directions.","volume":"19","author":"Wang","year":"2025","journal-title":"Drug Des Devel Ther."},{"key":"B49","doi-asserted-by":"publisher","first-page":"690341","DOI":"10.3389\/fphys.2021.690341","article-title":"Oxidative stress, kinase activation, and inflammatory pathways involved in effects on smooth muscle cells during pulmonary artery hypertension under hypobaric hypoxia exposure.","volume":"12","author":"Siques","year":"2021","journal-title":"Front Physiol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1719635\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T05:16:31Z","timestamp":1764566191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1719635\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":49,"alternative-id":["10.3389\/fmed.2025.1719635"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1719635","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"article-number":"1719635"}}